A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/16 (2006.01) A61P 9/10 (2006.01)
Patent
CA 2661012
A method for treating acute ischemic stroke in a human comprises administering tenecteplase to the human in a total dose of about 0.05 to 0.5 mg/kg, given as (a) an initial bolus dose of about 0.015 to 0.15 mg/kg, followed by infusion of an amount equaling the total dose minus the initial dose over a period of about 50-90 minutes, or (b) a bolus. Also described are kits for carrying out this method.
La présente invention concerne une méthode permettant de traiter un accident ischémique cérébral aigu chez un être humain, qui consiste à administrer audit être humain une dose totale de ténectéplase s'élevant à environ 0,05 à 0,5 mg/kg, ladite dose se décomposant en (a) un bolus initial d'environ 0,015 à 0,15 mg/kg, suivi de l'injection par perfusion d'une quantité égale à la dose totale moins la dose initiale sur une période de 50 à 90 minutes environ, ou (b) un bolus. L'invention concerne également des kits permettant de mettre en oeuvre ladite méthode.
Genentech Inc.
Smart & Biggar
LandOfFree
Method of treating stroke with thrombolytic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating stroke with thrombolytic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating stroke with thrombolytic agent will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1360395